所有图片(2)
About This Item
经验公式（希尔记法）:
C12H18ClNO · HCl
CAS号:
分子量:
264.19
MDL编号:
UNSPSC代码:
41116107
PubChem化学物质编号:
NACRES:
NA.24
推荐产品
等级
analytical standard
质量水平
产品线
VETRANAL®
方案
≥98.0% (HPLC)
技术
HPLC: suitable
gas chromatography (GC): suitable
solid phase extraction (SPE): suitable
应用
forensics and toxicology
pharmaceutical (small molecule)
veterinary
包装形式
neat
储存温度
2-8°C
SMILES字符串
Cl.CC(C)(C)NCC(O)c1ccccc1Cl
InChI
1S/C12H18ClNO.ClH/c1-12(2,3)14-8-11(15)9-6-4-5-7-10(9)13;/h4-7,11,14-15H,8H2,1-3H3;1H
InChI key
RSLNRVYIRDVHLY-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
一般描述
Supelco MIP SPE柱的标准品。有关更多信息，请索要Supelco文献T407075、T706019、T706030、T706020
盐酸妥洛特罗是一种拟交感神经胺，具有支气管扩张剂的活性。
应用
有关合适仪器技术的更多信息，请参考产品分析证书。如需进一步支持，请联系技术服务。
盐酸妥洛特罗可作为参考标准品，通过气相色谱-串联质谱（GC-MS-MS）测定牛肝匀浆和尿液样品中盐酸妥洛特罗的浓度。
包装
无底玻璃瓶。内含物在插入的融合锥体内。
法律信息
VETRANAL is a registered trademark of Merck KGaA, Darmstadt, Germany
警示用语：
Warning
危险声明
危险分类
Acute Tox. 4 Oral
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
个人防护装备
dust mask type N95 (US), Eyeshields, Gloves
法规信息
监管及禁止进口产品
Shuwa Minami et al.
Internal medicine (Tokyo, Japan), 47(6), 503-509 (2008-03-18)
There is insufficient evidence for the efficacy of a transdermal tulobuterol patch (TP), although combination therapy with bronchodilators is recommended for chronic obstructive pulmonary disease (COPD). A randomized, controlled crossover study was conducted to evaluate the clinical efficacy and safety
Ki-Seok Kim et al.
Colloids and surfaces. B, Biointerfaces, 80(2), 240-246 (2010-07-14)
pH sensitive Pluronic F127 (PF127)/poly(acrylic acid) (PAAc) hydrogels containing tulobuterol-loaded silica were prepared with PF127 content. The effects of the PF127 content and silica on the sustained release behaviors of the PAAc hydrogels were investigated. The results showed that the
Ki-Seok Kim et al.
Colloids and surfaces. B, Biointerfaces, 92, 240-245 (2011-12-30)
Porous poly(ε-caprolactone) (PCL)/Eudragit RS 100 (ERS-100) microcapsules containing tulobuterol-adsorbed silica nanotubes (S-NTs) were prepared using a solvent evaporation method. The release behaviors of the PCL/ERS-100 microcapsules were investigated as a function of S-NT content. The PCL/ERS-100 microcapsules showed a stable
Masakazu Ichinose et al.
Respiratory medicine, 104(2), 267-274 (2009-10-31)
The current mainstream treatment for COPD is bronchodilators alone or in combination. The effects of a beta(2)-agonist, tulobuterol, administered transdermally, have been reported to last for 24h. However, there are no reports on the efficacy of tulobuterol combined with an
Determination of tulobuterol in human plasma by capillary gas chromatography
Wood G S and Chasseaud F L.
Journal of Chromatography. B, Biomedical Sciences and Applications, 416, 154-159 (1987)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门